Chuck, I agree. I have been in this stock for many years also and do admit I had a lot animosity once the Lanzaslide effect hit my position and all the skeletons came out of the ACT closet. It was a downward spiral that worried me to say the least. I was not a happy camper on the stock but seeing all the great clinical data (still waiting on the official 100k cohort report) released it has giving me a warm and fuzzy about my position.
IMO this current pps will not stay this low for long and is going to breakout to the upside.
Market Data 
Markets 
AI
